Press Releases
Mondelēz International Reports Q4 and FY 2024 Results
FY'24 Net Revenues +1.2%, Organic Net Revenues1 +4.3%, Volume/Mix -1.0%
By Mondelez International, Inc. · Via GlobeNewswire · February 4, 2025
NYSE American to Suspend Trading in Regional Health Properties, Inc. (RHE)
NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to suspend trading in the two securities enumerated below (“Securities”) of Regional Health Properties, Inc. (the “Company”) from the Exchange. The staff suspended trading in the Company’s Securities because the Listings Qualifications Panel (the “Panel”) of the Committee for Review of the Board of Directors of the Exchange (the “Committee”) had issued a decision in which it upheld the Exchange’s previously announced determination to delist the Company’s Securities.
By NYSE Regulation · Via Business Wire · February 4, 2025
Buenaventura Issues 144A/Reg S Offering of US$650 million Senior Unsecured Notes Due 2032
Compañia de Minas Buenaventura S.A.A. (“Buenaventura” or “the Company”) (NYSE: BVN; Lima Stock Exchange: BUE.LM), Peru’s largest publicly-traded precious metals mining company, announced today the successful issuance of its senior unsecured notes (the “Notes”) due 2032 in an aggregate amount of US$650 million. The Notes mature on February 4, 2032 and bear interest at a rate of 6.800% per annum.
By Compañía de Minas Buenaventura S.A.A. · Via Business Wire · February 4, 2025
Down-The-Hole Hammer With Valveless Air Cycle For Oil & Gas Contractors Launched
Center Rock Inc. (814-267-7100) has expanded its range of down-the-hole (DTH) and rock drill bits for the oil and gas drilling sector.
Via Press Release Distribution Service · February 4, 2025
Amdocs Limited Reports First Quarter Fiscal 2025 Results
Revenue of $1.11 Billion, down 10.9% YoY as Reported and up 1.7% YoY in Pro Forma(1) Constant Currency(2)
Via ACCESS Newswire · February 4, 2025
Zurn Elkay Water Solutions Reports Fourth Quarter and Full Year 2024 Financial Results
Zurn Elkay Water Solutions Corporation (NYSEZWS)
By Zurn Elkay Water Solutions Corporation · Via Business Wire · February 4, 2025
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 16,500 shares of Astria’s common stock on February 3, 2025 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria.
By Astria Therapeutics, Inc. · Via Business Wire · February 4, 2025
Snap Inc. Announces Fourth Quarter and Full Year 2024 Financial Results
Snap Inc. (NYSESNAP) today announced financial results for the quarter and full year ended December 31, 2024.
By Snap Inc. · Via Business Wire · February 4, 2025
Champion Homes Announces Third Quarter Fiscal 2025 Results
Champion Homes, Inc. (NYSESKY) (“Champion Homes”) today announced financial results for its third quarter ended December 28, 2024 (“fiscal 2025”).
By Champion Homes, Inc. · Via Business Wire · February 4, 2025
A10 Networks Reports Fourth Quarter and Full Year 2024 Financial Results
A10 Networks, Inc. (NYSE: ATEN or the “Company”), a leading provider of cybersecurity and infrastructure solutions, today announced financial results for its fourth quarter and full year ended December 31, 2024.
By A10 Networks · Via Business Wire · February 4, 2025
Carlisle Companies Reports Fourth Quarter Results
Carlisle Companies Incorporated (NYSECSL) today announced its fourth quarter 2024 financial results.
By Carlisle Companies Incorporated · Via Business Wire · February 4, 2025
Electronic Arts Reports Q3 FY25 Results
Electronic Arts Inc. (NASDAQEA) today announced preliminary financial results for its third quarter ended December 31, 2024.
By Electronic Arts · Via Business Wire · February 4, 2025
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
Medifast (NYSEMED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2024 on Tuesday, February 18, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
By Medifast · Via Business Wire · February 4, 2025
Mattel Reports Fourth Quarter and Full Year 2024 Financial Results
Mattel, Inc. (NASDAQMAT) today reported fourth quarter and full year 2024 financial results.
By Mattel, Inc. · Via Business Wire · February 4, 2025
Columbia Sportswear Company Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Full Year 2025 Financial Outlook
Columbia Sportswear Company (NASDAQ: COLM, the "Company"), a multi-brand global leading innovator in outdoor, active and lifestyle products including apparel, footwear, accessories, and equipment, today announced fourth quarter 2024 financial results for the period ended December 31, 2024.
By Columbia Sportswear Company · Via Business Wire · February 4, 2025
The AZEK Company Announces First Quarter Fiscal 2025 Results; Raises Full-Year Fiscal 2025 Net Sales and Adjusted EBITDA Outlook
The AZEK Company Inc. (NYSEAZEK) (“AZEK” or the “Company”), the industry-leading manufacturer of beautiful, low-maintenance and environmentally sustainable outdoor living products, including TimberTech® Decking and Railing, Versatex® and AZEK® Trim and StruXure® pergolas, today announced financial results for its fiscal first quarter ended December 31, 2024.
By The AZEK Company Inc. · Via Business Wire · February 4, 2025
CCC Intelligent Solutions Announces Date of Fourth Quarter 2024 Earnings Call
CCC Intelligent Solutions Holdings Inc. (CCC) (NASDAQCCCS), a leading cloud platform powering the P&C insurance economy, announced today it will release its financial results for the quarter and full fiscal year 2024, ended December 31, 2024, after the U.S. financial markets close on Tuesday, February 25, 2025.
By CCC Intelligent Solutions Inc. · Via Business Wire · February 4, 2025
Western Union Reports Fourth Quarter and Full Year 2024 Results
The Western Union Company (the “Company” or “Western Union”) (NYSEWU) today reported fourth quarter and full year 2024 financial results.
By The Western Union Company · Via Business Wire · February 4, 2025
QIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the German Federal Patent Court (Bundespatentgericht) has ruled in its favor in a patent dispute against SD Biosensor, reaffirming the validity of an important patent protecting key innovations in its QuantiFERON technology.
By QIAGEN N.V. · Via Business Wire · February 4, 2025
Aspen Technology Announces Financial Results for the Second Quarter of Fiscal 2025
Aspen Technology, Inc. (“AspenTech” or the “Company”) (NASDAQAZPN), a global leader in industrial software, today announced financial results for its second quarter in fiscal 2025, ended December 31, 2024.
By Aspen Technology, Inc. · Via Business Wire · February 4, 2025
Olo Announces Date of Fourth Quarter and Fiscal Year 2024 Earnings Call
Olo Inc. (NYSEOLO), a leading restaurant technology provider, today announced that it will report its fourth quarter and fiscal year 2024 financial results after the U.S. financial markets close on Tuesday, February 25, 2025.
By Olo Inc. · Via Business Wire · February 4, 2025
Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 17/083,771 entitled Process for the Preparation of Erythrocytes Loaded With One or More Substances of Pharmaceutical Interest and So Obtained Erythrocytes. The newly allowed application covers the method of treating patients with Ataxia-Telangiectasia (A-T) and provides patent coverage for preparing erythrocytes loaded with one or more substances of pharmaceutical interest using the EryDex process. The first independent claim of this application is not limited to any particular pharmaceutical product and is broader than currently granted parent patent claims. Supplementing the company’s existing U.S. Patent No. 10,849,858, Quince now has issued patents directed to the process for encapsulating erythrocytes with a therapeutic drug as well as a method of treating a patient with encapsulated erythrocytes.
By Quince Therapeutics, Inc. · Via Business Wire · February 4, 2025
Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 Outlook
Oscar Health, Inc. (“Oscar” or the “Company”) (NYSEOSCR), a leading healthcare technology company, today announced its financial results for the fourth quarter and full year ended December 31, 2024.
By Oscar Health, Inc. · Via Business Wire · February 4, 2025
8x8, Inc. Announces Third Quarter Fiscal Year 2025 Financial Results
8x8, Inc. (NASDAQEGHT), the industry's most integrated Platform for CX that combines Contact Center, Unified Communication, and CPaaS APIs, today reported financial results for the third quarter of fiscal year 2025 ended December 31, 2024.
By 8x8, Inc. · Via Business Wire · February 4, 2025
Golden Entertainment to Report 2024 Fourth Quarter and Full Year Results on February 27 and Host Conference Call and Webcast
Golden Entertainment, Inc. (NASDAQGDEN) (“Golden Entertainment” or the “Company”) announced today that it will release its 2024 fourth quarter and full year financial results after the market closes on Thursday, February 27, 2025, and host a conference call and simultaneous webcast at 5:00 p.m. ET (2:00 p.m. PT) that day. Both the call and webcast are open to the general public.
By Golden Entertainment, Inc. · Via Business Wire · February 4, 2025
Ichor Holdings, Ltd. Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Ichor Holdings, Ltd. (NASDAQICHR), a leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment, today announced fourth quarter and fiscal year 2024 financial results.
By Ichor Holdings, Ltd. · Via Business Wire · February 4, 2025
ASGN Incorporated to Acquire TopBloc, A Preferred Workday Services Partner
ASGN Incorporated (NYSEASGN), a leading provider of IT services and professional solutions across the commercial and government sectors, announced today that it has signed a definitive agreement to acquire TopBloc, LLC (“TopBloc” or “the Company”), a leading, high-growth, tech-enabled Workday consultancy, for $340 million in cash and equity. The transaction, which is subject to Hart-Scott Rodino (HSR) and other customary closing conditions, is expected to close in the first quarter of 2025.
By ASGN Incorporated · Via Business Wire · February 4, 2025
AdaptHealth Corp. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
AdaptHealth Corp. (NASDAQAHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2024 financial results before the opening of the financial markets on Tuesday, February 25, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors.
By AdaptHealth Corp. · Via Business Wire · February 4, 2025
Intapp Announces Second Quarter Fiscal Year 2025 Financial Results
PALO ALTO, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Intapp, Inc. (NASDAQINTA), a leading global provider of AI-powered solutions for professionals at advisory, capital markets, and legal firms, announced financial results for its fiscal second quarter ended December 31, 2024. Intapp also provided its outlook for the third quarter and the full fiscal year 2025.
By Intapp Inc. · Via GlobeNewswire · February 4, 2025
Latham Group, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call Date
LATHAM, N.Y., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Latham Group, Inc. (Nasdaq: SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that it will release financial results for the fourth quarter and full year 2024 on Tuesday, March 4, 2025, after the close of the U.S. market. The Company will hold a conference call to discuss the results that same day at 4:30 PM Eastern Time.
By Latham Pool Products · Via GlobeNewswire · February 4, 2025
Runway Growth Finance Corp. Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
MENLO PARK, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it will release its fourth quarter and full year 2024 financial results after market close on Thursday, March 20, 2025. Runway Growth will discuss its financial results on a conference call that day at 2:00 p.m. PT (5:00 p.m. ET).
By Runway Growth Finance Corp. · Via GlobeNewswire · February 4, 2025
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
MINNEAPOLIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the fourth quarter and full year of 2024.
By CVRx, Inc. · Via GlobeNewswire · February 4, 2025
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
FORT LEE, NJ, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that it has commenced an underwritten public offering of its common stock. All of the shares to be sold in the offering will be offered by Nuvectis. In addition, Nuvectis intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
By Nuvectis Pharma, Inc. · Via GlobeNewswire · February 4, 2025
InnovAge Announces Financial Results For the Fiscal Second Quarter Ended December 31, 2024
DENVER, Feb. 04, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal second quarter ended December 31, 2024.
By InnovAge · Via GlobeNewswire · February 4, 2025
Exagen Inc. to Participate in Upcoming Investor Conferences
CARLSBAD, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming investor conferences:
By Exagen Inc. · Via GlobeNewswire · February 4, 2025
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the company approved the grant of equity awards to three new employees with a grant date of February 3, 2025, as equity inducement awards outside of the company's 2017 Stock Incentive Plan (but under the terms of the 2020 Inducement Stock Incentive Plan) and material to the employees’ acceptance of employment with the company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
By Apellis Pharmaceuticals, Inc. · Via GlobeNewswire · February 4, 2025
New York City Child Custody and Visitation Lawyer Juan Luciano Explains When a Child Can Refuse to See a Parent
New York City child custody and visitation lawyer Juan Luciano ( https://divorcelawfirmnyc.com/at-what-age-can-a-child-refuse-to-see-a-parent/ ) has provided crucial insights into one of the most emotionally challenging issues for parents managing divorce or separation: a child’s refusal to visit a parent. In the latest article, Luciano examines the legal, emotional, and practical aspects of enforcing visitation orders when children resist spending time with a non-custodial parent.
Via AB Newswire · February 4, 2025
Slightly Stoopid, Damian & Stephen Marley to headline Everwild Music Festival in 2025
Everwild returns to Legend Valley with its largest lineup ever for the festival's fifth edition.THORNVILLE, Ohio - Feb. 4, 2025 - PRLog -- Everwild Music Festival, which has quickly become a mainstay in the Midwest summer festival circuit, today announced its full 2025 lineup, headlined by Slightly Stoopid and Damian & Stephen Marley, alongside can't-miss national acts Iration, J Boog, and host band Tropidelic. More than two dozen other bands round out the festival lineup, set to take place July 31-Aug. 2, 2025, at the iconic 230-acre Legend Valley Concert Venue in Thornville, Ohio,Located just a half-hour east of Columbus, Ohio, Legend Valley has hosted major events for more than four decades, with legendary performances from artists ranging from the Grateful Dead to Jimmy Buffett to Metallica. This will be the fourth consecutive year that Legend Valley will play host to Everwild, with the festival seeing exponential growth since its inception in 2022 to its largest event yet in 2024, when more than 7,000 people per day graced the festival grounds.In addition to three full days of music and camping, Everwild features a variety of food and craft vendors, a full Artist Village showcasing work from renowned regional artists, daily yoga sessions, and three stages of music with no overlapping sets.Other acts on the 2025 Everwild lineup include Little Stranger, Fortunate Youth, Shwayze, Kash'd Out, Surfer Girl, Artikal Sound System, and many others.Three-day general admission tickets are on sale now starting at $199, which includes free basic camping and parking. VIP tickets — which have sold out in each of the past three years — start at $389 and include access to flushable toilets and private showers, entry to the VIP tent near the main stage, band meet-and-greets, and other perks. A limited number of electric and non-electric RV sites are also available for purchase. As always, kids 12 & under will be admitted free of charge.Tickets and more information can be found at everwildfestival.com.
Via PRLog · February 4, 2025
New memoir “Grandma Chuy’s Secret Recipe” by R.Z. Kilborn is released, a touching reflection on disability, superstition, family secrets, and adapting to life’s challenges
“Grandma Chuy’s Secret Recipe” by R.Z. Kilborn has been released worldwide. This 168-page memoir, which has achieved Amazon Bestseller status as #1 in the “Biographies of People with Disabilities (Books)” category, #16 in the “Biographies & Memoirs of Women” category, and #13 in the “Family Relationships (Kindle Store)” category, breaks the author’s 28-year silence about the circumstances surrounding her disability, taking a candid, often humorous approach to tragic experiences. Kilborn, who became disabled at the age of 9, shares the circumstances of her young life and connects them to the larger topics of social stigma, cultural perspectives, family hardship, and the folklore that can drive beliefs. As a child, she believed herself to be a victim of her grandmother’s curse.
Via AB Newswire · February 4, 2025
Altisource Announces Proposed Distribution of Warrants to Purchase Common Stock and Sets February 14, 2025 as the Record Date For Proposed Distribution
LUXEMBOURG, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (Nasdaq: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced a proposed issuance under Luxembourg law under the authorized share capital mechanism, which is more commonly referred to as a distribution in the United States (the “Warrant Distribution”), of transferable Warrants (as defined below) to holders (collectively, the “Stakeholders”) of Altisource’s (i) common stock (the “Common Stock”), (ii) restricted share units (“RSUs”) and (iii) outstanding warrants to purchase shares of Common Stock at an exercise price of $0.01 per share (“Existing Warrants”), in each case, as of 5:00 p.m., New York City time, on February 14, 2025 (the “Distribution Record Date”). The Warrant Distribution is contingent upon, among other things, approval by the Company’s shareholders of the proposals set forth in the Company’s definitive proxy statement on Schedule 14A filed with the SEC on January 3, 2025 (the “Proxy Statement”) and the consummation of the transactions contemplated by that certain previously disclosed Transaction Support Agreement (the “Transactions”), which Transactions are summarized in the Proxy Statement.
By Altisource Portfolio Solutions S.A. · Via GlobeNewswire · February 4, 2025
The Manitowoc Company Expands its Direct-to-Customer Footprint in Georgia, North Carolina, and South Carolina
The Manitowoc Company, Inc. (NYSEMTW) (“the Company” or “Manitowoc”), a leading global manufacturer of cranes and lifting solutions, announced today that through its wholly- owned subsidiary, MGX Equipment Services, LLC, it has completed the acquisition of certain crane assets of Ring Power Corporation (“Ring Power”). This transaction expands Manitowoc’s direct-to-customer footprint in the territories with new and used crane sales, aftermarket parts, service, and remanufacturing support to a diverse range of end market customers. MGX will now serve crane customers in Georgia, North Carolina, and South Carolina. Ring Power will maintain its current facilities in Georgia, North Carolina, and South Carolina for its utility and vocational truck operations. In addition, Ring Power will operate its crane business in Florida representing Grove, Manitowoc, and National Crane products.
By The Manitowoc Company, Inc. · Via Business Wire · February 4, 2025
Jeff Woolard Named Cirrus Logic Chief Financial Officer
Cirrus Logic, Inc. (NASDAQCRUS) today announced the appointment of Jeff Woolard as chief financial officer, effective February 24, 2025. Jeff has more than 30 years of experience in the technology industry with extensive knowledge of corporate finance and strategy, M&A, new business incubation and business optimization. He has also served on the Board of Directors for McAfee Corp., a computer security software company, and Care Innovations, a private company focused on technology-based healthcare.
By Cirrus Logic, Inc. · Via Business Wire · February 4, 2025
TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQMRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Aldevron, a leading, global Contract Development and Manufacturing Organization (CDMO) providing high-quality plasmid DNA, RNA, and proteins for research, therapeutics, and diagnostics. With this agreement with Aldevron, TriLink strengthens its objective to provide greater access to CleanCap® mRNA capping technologies to those developing critical mRNA-based therapeutics and vaccines.
By TriLink BioTechnologies · Via Business Wire · February 4, 2025
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQFATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on February 3, 2025 the Company granted (i) non-qualified stock options to one newly-hired non-executive employee to purchase a total of 35,000 shares of the Company’s common stock at an exercise price per share of $1.27, which was the closing price per share of the Company’s common stock as reported by NASDAQ on February 3, 2025, the options grant date, and (ii) restricted stock units (RSUs) representing 20,400 shares of its common stock to two newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% vesting in approximately equal monthly installments over the following thirty-six months, subject to the employee being continuously employed by the Company through each vesting date. The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employees being continuously employed by the Company through each vesting date.
By Fate Therapeutics, Inc. · Via GlobeNewswire · February 4, 2025
Optimal Blue Introduces Seven Major Innovations at Its Inaugural User Summit in San Diego
SAN DIEGO, Calif., Feb. 4, 2025 (SEND2PRESS NEWSWIRE) -- Optimal Blue today unveiled a series of new products and features, alongside its major Ask Obi AI assistant announcement, at its Summit user conference in San Diego. These innovation announcements underscore the company's commitment to delivering high-impact solutions, at no additional cost, that tackle real-world challenges and help lenders maximize profitability. - News from Optimal Blue, issued by Send2Press Newswire
Via Send2Press · February 4, 2025
USO Announces Goal to Collect Two Million Messages of Support for U.S. Service Members
Arlington, VA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- On its 84th birthday, the USO announced its birthday wish for 2025 is to collect two million messages of support this year to honor the more than two million people serving in the U.S. military and the families who stand by their side. The messages will be displayed at over 250 USO Centers worldwide in high-traffic, visible locations where service members are most likely to see them.
By USO · Via GlobeNewswire · February 4, 2025
Pierrette Kengela Launches E-Learning Academy to Empower Women and Promote Health Equity
Cape Town, South Africa - February 4, 2025 - Renowned global health expert, women’s leadership advocate, executive life coach, and published author, Pierrette Kengela, is proud to announce the launch of her E-learning Academy, a transformative platform designed to provide self-development, career coaching, and mentorship. The academy, which officially launched on February 1st, offers courses inspired by Kengela’s book and her impactful career journey, aimed at empowering individuals globally, with a special focus on women’s leadership and health equity.
Via AB Newswire · February 4, 2025
Horizon Space Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on February 5, 2025
NEW YORK CITY, NY / ACCESS Newswire / February 4, 2025 / Horizon Space Acquisition II Corp. (the "Company") (Nasdaq:HSPT), a blank check company, today announced that, commencing on February 5, 2025, holders of the 5,750,000 units (the "Units") sold in the Company's initial public offering (the "Offering") including Units sold upon a full exercise of the underwriters' over-allotment option, may elect to separately trade the ordinary shares and rights included in the Units. Any Units not separated will continue to trade on the NASDAQ Global Market ("NASDAQ") under the symbol "HSPTU." Any underlying ordinary shares and rights that are separated will trade on the NASDAQ under the symbols "HSPT" and "HSPTR," respectively. Holders of Units will need to have their brokers contact the Company's transfer agent, VStock Transfer, LLC, in order to separate the holders' Units into ordinary shares and rights.
Via ACCESS Newswire · February 4, 2025
Viking Masek Robotics & Automation Announces Strategic Name Change to Blue Onyx Systems
NEW BERLIN, WI / ACCESS Newswire / February 4, 2025 / Viking Masek Robotics & Automation, a leading Robotics & Automation integrator, today announced that it is changing its corporate name to Blue Onyx Systems effective January 31, 2025. This strategic rebrand reflects the company's continued evolution, and its commitment to stay at the forefront of today's progressive technology market landscape, while staying true to its core purpose of Elevating Performance by Connecting Imagination with Technology.
Via ACCESS Newswire · February 4, 2025
Cirrus Logic Reports Fiscal Third Quarter Revenue of $555.7 Million
Cirrus Logic, Inc. (NASDAQCRUS) today posted on its website at investor.cirrus.com the quarterly Shareholder Letter that contains the complete financial results for the third quarter of fiscal year 2025, which ended December 28, 2024, as well as the company’s current business outlook.
By Cirrus Logic, Inc. · Via Business Wire · February 4, 2025